<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7454939</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0237560</article-id><article-id pub-id-type="publisher-id">PONE-D-19-15582</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Geographical Locations</subject><subj-group><subject>Asia</subject><subj-group><subject>Pakistan</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Earth Sciences</subject><subj-group><subject>Geography</subject><subj-group><subject>Human Geography</subject><subj-group><subject>Urban Geography</subject><subj-group><subject>Cities</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Social Sciences</subject><subj-group><subject>Human Geography</subject><subj-group><subject>Urban Geography</subject><subj-group><subject>Cities</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Evolutionary Biology</subject><subj-group><subject>Evolutionary Systematics</subject><subj-group><subject>Phylogenetics</subject><subj-group><subject>Phylogenetic Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Taxonomy</subject><subj-group><subject>Evolutionary Systematics</subject><subj-group><subject>Phylogenetics</subject><subj-group><subject>Phylogenetic Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Computer and Information Sciences</subject><subj-group><subject>Data Management</subject><subj-group><subject>Taxonomy</subject><subj-group><subject>Evolutionary Systematics</subject><subj-group><subject>Phylogenetics</subject><subj-group><subject>Phylogenetic Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Evolutionary Biology</subject><subj-group><subject>Evolutionary Systematics</subject><subj-group><subject>Phylogenetics</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Taxonomy</subject><subj-group><subject>Evolutionary Systematics</subject><subj-group><subject>Phylogenetics</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Computer and Information Sciences</subject><subj-group><subject>Data Management</subject><subj-group><subject>Taxonomy</subject><subj-group><subject>Evolutionary Systematics</subject><subj-group><subject>Phylogenetics</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Evolutionary Biology</subject><subj-group><subject>Population Genetics</subject><subj-group><subject>Effective Population Size</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Population Genetics</subject><subj-group><subject>Effective Population Size</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Population Biology</subject><subj-group><subject>Population Genetics</subject><subj-group><subject>Effective Population Size</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Population Biology</subject><subj-group><subject>Population Metrics</subject><subj-group><subject>Effective Population Size</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Population Biology</subject><subj-group><subject>Population Metrics</subject><subj-group><subject>Population Size</subject><subj-group><subject>Effective Population Size</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Geographical Locations</subject><subj-group><subject>Asia</subject><subj-group><subject>Afghanistan</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Behavioral Pharmacology</subject><subj-group><subject>Recreational Drug Use</subject><subj-group><subject>Heroin</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>HIV-1 phylodynamic analysis among people who inject drugs in Pakistan correlates with trends in illicit opioid trade</article-title><alt-title alt-title-type="running-head">HIV-1 phylodynamic analysis correlates with trends in illicit opioid trade in Pakistan</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8706-8128</contrib-id><name><surname>Cholette</surname><given-names>Fran&#x000e7;ois</given-names></name><role content-type="https://casrai.org/credit/">Conceptualization</role><role content-type="https://casrai.org/credit/">Formal analysis</role><role content-type="https://casrai.org/credit/">Investigation</role><role content-type="https://casrai.org/credit/">Methodology</role><role content-type="https://casrai.org/credit/">Project administration</role><role content-type="https://casrai.org/credit/">Supervision</role><role content-type="https://casrai.org/credit/">Visualization</role><role content-type="https://casrai.org/credit/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Joy</surname><given-names>Jeffrey</given-names></name><role content-type="https://casrai.org/credit/">Formal analysis</role><role content-type="https://casrai.org/credit/">Methodology</role><role content-type="https://casrai.org/credit/">Supervision</role><role content-type="https://casrai.org/credit/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pelcat</surname><given-names>Yann</given-names></name><role content-type="https://casrai.org/credit/">Formal analysis</role><role content-type="https://casrai.org/credit/">Visualization</role><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Thompson</surname><given-names>Laura H.</given-names></name><role content-type="https://casrai.org/credit/">Methodology</role><role content-type="https://casrai.org/credit/">Project administration</role><role content-type="https://casrai.org/credit/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pilon</surname><given-names>Richard</given-names></name><role content-type="https://casrai.org/credit/">Methodology</role><role content-type="https://casrai.org/credit/">Project administration</role><role content-type="https://casrai.org/credit/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ho</surname><given-names>John</given-names></name><role content-type="https://casrai.org/credit/">Formal analysis</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Capina</surname><given-names>Rupert</given-names></name><role content-type="https://casrai.org/credit/">Formal analysis</role><role content-type="https://casrai.org/credit/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Archibald</surname><given-names>Chris</given-names></name><role content-type="https://casrai.org/credit/">Conceptualization</role><role content-type="https://casrai.org/credit/">Supervision</role><xref ref-type="aff" rid="aff007"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Blanchard</surname><given-names>James F.</given-names></name><role content-type="https://casrai.org/credit/">Investigation</role><role content-type="https://casrai.org/credit/">Methodology</role><role content-type="https://casrai.org/credit/">Project administration</role><role content-type="https://casrai.org/credit/">Resources</role><role content-type="https://casrai.org/credit/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff008"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Emmanuel</surname><given-names>Faran</given-names></name><role content-type="https://casrai.org/credit/">Conceptualization</role><role content-type="https://casrai.org/credit/">Investigation</role><role content-type="https://casrai.org/credit/">Methodology</role><role content-type="https://casrai.org/credit/">Project administration</role><xref ref-type="aff" rid="aff008"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Reza</surname><given-names>Tahira</given-names></name><role content-type="https://casrai.org/credit/">Investigation</role><role content-type="https://casrai.org/credit/">Methodology</role><role content-type="https://casrai.org/credit/">Project administration</role><role content-type="https://casrai.org/credit/">Resources</role><role content-type="https://casrai.org/credit/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff009"><sup>9</sup></xref></contrib><contrib contrib-type="author"><name><surname>Dar</surname><given-names>Nosheen</given-names></name><role content-type="https://casrai.org/credit/">Investigation</role><role content-type="https://casrai.org/credit/">Methodology</role><role content-type="https://casrai.org/credit/">Project administration</role><role content-type="https://casrai.org/credit/">Resources</role><xref ref-type="aff" rid="aff010"><sup>10</sup></xref></contrib><contrib contrib-type="author"><name><surname>Harrigan</surname><given-names>Richard</given-names></name><role content-type="https://casrai.org/credit/">Supervision</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>John</given-names></name><role content-type="https://casrai.org/credit/">Supervision</role><role content-type="https://casrai.org/credit/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sandstrom</surname><given-names>Paul</given-names></name><role content-type="https://casrai.org/credit/">Methodology</role><role content-type="https://casrai.org/credit/">Supervision</role><role content-type="https://casrai.org/credit/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff011"><sup>11</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>National HIV and Retrovirology Laboratories, National Microbiology Laboratory at the JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, Manitoba, Canada</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Bioinformatics Programme, University of British Columbia, Vancouver, British Columbia, Canada</addr-line></aff><aff id="aff006"><label>6</label>
<addr-line>Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Saint-Hyacinthe, Qu&#x000e9;bec, Canada</addr-line></aff><aff id="aff007"><label>7</label>
<addr-line>Centre for Communicable Diseases and Infection Control, Surveillance and Epidemiology Division, Public Health Agency of Canada, Ottawa, Ontario, Canada</addr-line></aff><aff id="aff008"><label>8</label>
<addr-line>Centre for Global Public Health, University of Manitoba, Winnipeg, Canada</addr-line></aff><aff id="aff009"><label>9</label>
<addr-line>Centre for Global Public Health, Pakistan, Chak Shahzad, Islamabad, Pakistan</addr-line></aff><aff id="aff010"><label>10</label>
<addr-line>Canada-Pakistan HIV/AIDS Surveillance Project, Islamabad, Pakistan</addr-line></aff><aff id="aff011"><label>11</label>
<addr-line>Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Blackard</surname><given-names>Jason</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>University of Cincinnati College of Medicine, UNITED STATES</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>Paul.Sandstrom@Canada.ca</email></corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>8</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>15</volume><issue>8</issue><elocation-id>e0237560</elocation-id><history><date date-type="received"><day>1</day><month>6</month><year>2019</year></date><date date-type="accepted"><day>30</day><month>7</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 Cholette et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Cholette et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0237560.pdf"/><abstract><p>Pakistan is considered by the World Health Organization to currently have a &#x0201c;concentrated&#x0201d; HIV-1 epidemic due to a rapid rise in infections among people who inject drugs (PWID). Prevalence among the country&#x02019;s nearly 105,000 PWID is estimated to be 37.8% but has been shown to be higher in several large urban centers. A lack of public health resources, the common use of professional injectors and unsafe injection practices are believed to have fueled the outbreak. Here we evaluate the molecular characteristics of HIV-1 sequences (n = 290) from PWID in several Pakistani cities to examine transmission dynamics and the association between rates of HIV-1 transmission with regards to regional trends in opioid trafficking. Tip-to-tip (patristic) distance based phylogenetic cluster inferences and BEAST2 Bayesian phylodynamic analyses of time-stamped data were performed on HIV-1 <italic>pol</italic> sequences generated from dried blood spots collected from 1,453 PWID as part of a cross-sectional survey conducted in Pakistan during 2014/2015. Overall, subtype A1 strains were dominant (75.2%) followed by CRF02_AG (14.1%), recombinants/unassigned (7.2%), CRF35_AD (2.1%), G (1.0%) and C (0.3%). Nearly three quarters of the PWID HIV-1 sequences belonged to one of five distinct phylogenetic clusters. Just below half (44.4%) of individuals in the largest cluster (n = 118) did seek help injecting from professional injectors which was previously identified as a strong correlate of HIV-1 infection. Spikes in estimated HIV-1 effective population sizes coincided with increases in opium poppy cultivation in Afghanistan, Pakistan&#x02019;s western neighbor. Structured coalescent analysis was undertaken in order to investigate the spatial relationship of HIV-1 transmission among the various cities under study. In general terms, our analysis placed the city of Larkana at the center of the PWID HIV-1 epidemic in Pakistan which is consistent with previous epidemiological data.</p></abstract><funding-group><funding-statement>The author(s) received no specific funding for this work.</funding-statement></funding-group><counts><fig-count count="5"/><table-count count="3"/><page-count count="17"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All data are available via a public repository (i.e. NCBI). Accession codes can be found in the supporting information file, <xref ref-type="supplementary-material" rid="pone.0237560.s002">S1 Table</xref>.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All data are available via a public repository (i.e. NCBI). Accession codes can be found in the supporting information file, <xref ref-type="supplementary-material" rid="pone.0237560.s002">S1 Table</xref>.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Pakistan is considered to have transitioned from a &#x0201c;low prevalence, high risk&#x0201d; to a &#x0201c;concentrated&#x0201d; epidemic stage owing primarily to a rapid rise in infections among people who inject drugs (PWID, <ext-link ext-link-type="uri" xlink:href="http://www.nacp.gov.pk/whatwedo/surveillance.html">www.nacp.gov.pk/whatwedo/surveillance.html</ext-link>) [<xref rid="pone.0237560.ref001" ref-type="bibr">1</xref>]. While HIV-1 prevalence within the general population remains below 0.1%, prevalence among the country&#x02019;s nearly 105,000 PWID is estimated to be 37.8% with even higher prevalence in selected urban centres (<ext-link ext-link-type="uri" xlink:href="http://www.nacp.gov.pk/whatwedo/surveillance.html">www.nacp.gov.pk/whatwedo/surveillance.html</ext-link>) [<xref rid="pone.0237560.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0237560.ref002" ref-type="bibr">2</xref>]. Perhaps more concerning is the significant rise in PWID associated HIV-1 prevalence over an extremely short interval that has been observed in certain cities, indicative of uncontrolled HIV-1 transmission resulting from a lack of public health resources. Concern remains that the HIV-1 epidemic within the country&#x02019;s PWID population could spread to other at-risk populations such as male, transgender and female sex workers, thereby intensifying epidemics in high risk sexual networks in Pakistan.</p><p>We previously reported an explosive HIV-1 epidemic among PWID in the central Pakistani city of Sargodha in Punjab province [<xref rid="pone.0237560.ref003" ref-type="bibr">3</xref>]. Sequential cross-sectional surveys revealed a significant increase in HIV-1 prevalence within Sargodha&#x02019;s PWID population from 9.0% in 2005&#x02013;2006 to 51.5% in 2006&#x02013;2007. The city is located along one of the country&#x02019;s most important drug trafficking routes, connecting opioid production areas in eastern Afghanistan with southern and central Pakistan, ultimately providing the city&#x02019;s estimated 2,500 PWID with easy access to inexpensive heroin (<ext-link ext-link-type="uri" xlink:href="http://www.unodc.org/documents/wdr/WDR_2010/World_Drug_Report_2010_lo-res.pdf">www.unodc.org/documents/wdr/WDR_2010/World_Drug_Report_2010_lo-res.pdf</ext-link>) [<xref rid="pone.0237560.ref004" ref-type="bibr">4</xref>]. Large sharing networks and unusual injection practices [<xref rid="pone.0237560.ref005" ref-type="bibr">5</xref>] which facilitate direct transfer of blood between individuals appear to be the main epidemic drivers [<xref rid="pone.0237560.ref003" ref-type="bibr">3</xref>]. The relationship between the HIV-1 outbreak in Sargodha and HIV-1 infections occurring in PWID or associated at risk populations in other regions of Pakistan remains unclear. In particular, a better understanding of the role that PWID migration between cities, for example as commercial truck drivers or migrant agricultural workers [<xref rid="pone.0237560.ref006" ref-type="bibr">6</xref>], plays in driving HIV-1 expansion will be critical for the development of sound and effective public health policies.</p><p>It has been reported that HIV-1 clade A1 infections in the Pakistani port city of Karachi may be the result of onward transmission among PWID of a highly similar founder virus [<xref rid="pone.0237560.ref007" ref-type="bibr">7</xref>]. Phylogenetic analysis of HIV-1 <italic>gag</italic> sequences derived from 26 HIV-1 positive PWID generated a single monophyletic clade A1 cluster with an inter-sequence identity of greater than 98%. In addition, Rai <italic>et al</italic>. (2010) deduced that the Karachi A1 HIV-1 epidemic was likely seeded by migrant contract workers who had been deported to Pakistan in the early 1990s after supposedly contracting HIV-1 through contact with sex workers in the Middle East. In this study, using HIV-1 sequence data from HIV-1 positive dried blood spot (DBS) specimens collected as part of a cross-sectional survey conducted in 2014, we sought to use phylodynamic methods to better understand the dynamics of HIV-1 transmission within Pakistan&#x02019;s at risk populations. Specifically, to examine HIV-1 transmission clusters within and among cities in Pakistan and test hypotheses concerning the association between rates of HIV-1 transmission and regional trends in opioid trafficking.</p></sec><sec sec-type="results" id="sec002"><title>Results</title><sec id="sec003"><title>Serology, amplification and sequencing</title><p>Serological testing for HIV-1 determined that 367 of the 1,453 (25.6%) 2014 PWID survey participants were HIV-1 reactive while seventeen did not have sufficient specimen for testing. Amplification and sequencing of HIV-1 was attempted on all available HIV-1 serology reactive PWID specimens. In total, we were able to amplify 290 <italic>pol</italic> sequences of the 367 (79.0%) available specimens. In general, 80% of the HIV-1 reactive DBS specimens could be amplified from each city except Hyderabad where amplification success was closer to 70%. The observed 20&#x02013;30% amplification failure was likely due to nucleic acid degradation during storage [<xref rid="pone.0237560.ref008" ref-type="bibr">8</xref>] and/or low viral loads (&#x02266; 1,000 copies/mL) [<xref rid="pone.0237560.ref009" ref-type="bibr">9</xref>]. Even though our HIV-1 genotyping primers have been validated in-house as part of the Canadian HIV-1 Strain and Drug Resistance Surveillance program, we cannot rule out the possibility of amplification failure attributed to poor primer annealing efficiency to sequences from unique HIV-1 circulating recombinant forms (CRFs) recently reported in Pakistan [<xref rid="pone.0237560.ref010" ref-type="bibr">10</xref>].</p></sec><sec id="sec004"><title>HIV-1 subtype distribution</title><p>Each viral sequence from our study was assigned a subtype based on an analysis performed with automated HIV-1 subtyping tools (<xref ref-type="supplementary-material" rid="pone.0237560.s002">S1 Table</xref>). The geographic distribution of HIV-1 subtypes among PWID is depicted in <xref ref-type="fig" rid="pone.0237560.g001">Fig 1</xref>. Overall, subtype A1 strains were dominant (75.2%) followed by CRF02_AG (14.1%), recombinants/unassigned (7.2%), CRF35_AD (2.1%), G (1.0%) and C (0.3%).</p><fig id="pone.0237560.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0237560.g001</object-id><label>Fig 1</label><caption><title>Geographic HIV-1 subtype distribution among people who inject drugs in Pakistan.</title><p>&#x0201c;Recomb&#x0201d; refers to HIV-1 sequences that were unsuccessfully subtyped (i.e. labelled as recombinant and/or unassigned) by the automated subtyping tools. This map was created using ESRI ArcMap software version 10.5., using open source data from the Global Administrative Areas version 2.8 (<ext-link ext-link-type="uri" xlink:href="https://gadm.org/data.html">https://gadm.org/data.html</ext-link>).</p></caption><graphic xlink:href="pone.0237560.g001"/></fig></sec><sec id="sec005"><title>Phylogenetic clusters</title><p>The ML analysis of PWID sequences was done with background sequences consisting of all available HIV-1 <italic>pol</italic> sequences from Pakistan in the Los Alamos HIV database as well as closely related sequences determined by BLASTn [<xref rid="pone.0237560.ref011" ref-type="bibr">11</xref>] searches. Details regarding these sequences can be found in <xref ref-type="supplementary-material" rid="pone.0237560.s003">S2 Table</xref>. The phylogenetic tree inferred by ML analysis (<xref ref-type="fig" rid="pone.0237560.g002">Fig 2a</xref>) reveals close relationship between PWID infections, most notably in Peshawar. Of particular interest, several HIV-1 subtype CRF35_AD PWID sequences from our study were nested among sequences from Afghanistan and the Islamic Republic of Iran (<xref ref-type="fig" rid="pone.0237560.g002">Fig 2b</xref>), supported by a high bootstrap value, suggesting a close genetic relationship.</p><fig id="pone.0237560.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0237560.g002</object-id><label>Fig 2</label><caption><title>Maximum likelihood phylogenetic tree for HIV-1 <italic>pol s</italic>equences (n = 561).</title><p>A) Viral strain sequences from people who inject drugs in Pakistan are annotated according to city of origin: Karachi (blue, n = 109 [19.4%]), Peshawar (orange, n = 94 [16.7%]), Hyderabad (purple, n = 42 [7.5%]), Larkana (green, n = 25 [4.5%]) and Quetta (red, n = 20 [3.6%]) while branches representing background sequences (n = 271 [48.3%]) were left black. Monophyletic clusters identified by Cluster Picker are highlighted by light grey bars. B) Sub-tree from principal maximum likelihood phylogenetic tree from HIV-1 <italic>pol</italic> sequences used for cluster analysis presenting HIV-1 subtype CRF35_AD sequences from people who inject drugs in Pakistan. The numbers on the branches represent the percentage of maximum likelihood ultra-fast bootstrap samples (100,000 replicates) where the node is supported by a value of &#x02265; 90%. Branches are annotated according to city or country of origin: Karachi (blue, n = 7 [20.0%]), Peshawar (orange, n = 1 [2.9%]), Hyderabad (purple, n = 1 [2.9%]), Quetta (red, n = 1 [2.9%]), Afghanistan (black, n = 10 [28.6%]), and grey (Iran, n = 15 [42.8%]).</p></caption><graphic xlink:href="pone.0237560.g002"/></fig><p>Out of the 290 HIV-1 sequences collected from PWIDs, 213 (73.5%) were associated with one of several phylogenetic clusters. In total, 5 distinct clusters ranging from 8 to 118 sequences in size were identified using tip-to-tip (patristic) distances (<xref rid="pone.0237560.t001" ref-type="table">Table 1</xref>, <xref ref-type="fig" rid="pone.0237560.g003">Fig 3</xref>). Altogether, the odds of clustering among sequences from PWID who sought help injecting drugs was 10.1% (OR 0.899; 95% CI, 0.523&#x02013;1.533) less compared to sequences from PWID who did not seek help injecting but this was found to be non-significant (X<sup>2</sup> = 0.064, df = 1, p&#x0003e;0.05).</p><fig id="pone.0237560.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0237560.g003</object-id><label>Fig 3</label><caption><title>Phylogenetic clusters inferred using tip-to-tip (patristic) distance between sequences measured on phylogenetic trees.</title><p>Viral strain sequences from people who inject drugs in Pakistan are annotated according to city of origin: Karachi (blue), Peshawar (orange), Hyderabad (purple), Larkana (green) and Quetta (red).</p></caption><graphic xlink:href="pone.0237560.g003"/></fig><table-wrap id="pone.0237560.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0237560.t001</object-id><label>Table 1</label><caption><title>Description of phylogenetic clusters identified by tip-to-tip (patristic) distances.</title></caption><alternatives><graphic id="pone.0237560.t001g" xlink:href="pone.0237560.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Cluster ID</th><th align="left" rowspan="2" colspan="1">Sequences (n =)</th><th align="left" colspan="5" rowspan="1">City</th><th align="left" colspan="3" rowspan="1">Help injecting</th></tr><tr><th align="left" rowspan="1" colspan="1">HYD (n =)</th><th align="left" rowspan="1" colspan="1">KAR (n =)</th><th align="left" rowspan="1" colspan="1">LAR (n =)</th><th align="left" rowspan="1" colspan="1">PES (n =)</th><th align="left" rowspan="1" colspan="1">QUE (n =)</th><th align="left" rowspan="1" colspan="1">Yes (n =)</th><th align="left" rowspan="1" colspan="1">No (n =)</th><th align="left" rowspan="1" colspan="1">N/A (n =)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">118</td><td align="left" rowspan="1" colspan="1">32</td><td align="left" rowspan="1" colspan="1">49</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">52</td><td align="left" rowspan="1" colspan="1">65</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">52</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">51</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">26</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">-</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>Hyderabad, HYD; Karachi, KAR; Larkana, LAR; Peshawar, PES; Quetta, QUE; information not available, N/A</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec006"><title>HIV-1 phylodynamics</title><p>Bayesian skyline plot analysis (<xref ref-type="fig" rid="pone.0237560.g004">Fig 4</xref>) for the period of 1994 to 2013 suggests that HIV-1 among PWID in Pakistan experienced an initial phase of exponential growth sometime around 2004 and peaked in 2006. Over the next two years, only minor changes to the median effective population size were observed until a second instance of exponential growth occurred around 2008 reaching a peak in 2012. Both spikes in HIV-1 median effective population size overlapped with increases in opium cultivation (<xref ref-type="fig" rid="pone.0237560.g004">Fig 4</xref>) in Pakistan&#x02019;s neighboring country to the west, Afghanistan. Overall, there was a positive correlation between median HIV-1 effective population size and opium cultivation (r = 0.46, n = 19, p &#x0003c; 0.001).</p><fig id="pone.0237560.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0237560.g004</object-id><label>Fig 4</label><caption><title>Effective population size estimates of HIV-1 among people who inject drugs in Pakistan.</title><p>The median effective population size is shown by the solid blue line, with the 95% highest and lowest posterior densities represented by the area shaded in blue. The timeframe dates back to the early 1980&#x02019;s but estimates up to 1994 only are displayed for legibility. Opium poppy cultivation in Afghanistan, according to estimates by the United Nations Office on Drugs and Crime [<xref rid="pone.0237560.ref012" ref-type="bibr">12</xref>], is represented by light orange bars.</p></caption><graphic xlink:href="pone.0237560.g004"/></fig><p>A structured coalescent based analysis was undertaken in order to investigate the spatial relationship of HIV-1 transmission among the various cities under study. The analysis was limited to subtype A1 sequences since it represents the prevalent strain of HIV-1 circulating among PWID in Pakistan. Inferred HIV-1 migrations between cities can be found in <xref rid="pone.0237560.t002" ref-type="table">Table 2</xref> and <xref ref-type="fig" rid="pone.0237560.g005">Fig 5</xref> while the relevant maximum clade credibility (MCC) tree is provided in <xref ref-type="supplementary-material" rid="pone.0237560.s001">S1 Fig</xref>. In general, the highest number of southward HIV-1 migrations events were observed from Quetta to Larkana (5.18 &#x000b1; 3.85 HIV-1 migration events) and Peshawar to Quetta (6.84 &#x000b1; 3.86 HIV-1 migration events) while the highest northward migrations rates were observed from Karachi to Larkana (36.60 &#x000b1; 24.08 HIV-1 migration events) and Larkana to Quetta (58.66 &#x000b1; 24.78 HIV-1 migration events). Although, the majority of the ancestral nodes were poorly supported according to the MCC tree (posterior probability &#x0003c;0.70, <xref ref-type="supplementary-material" rid="pone.0237560.s001">S1 Fig</xref>). This was most likely due to polytomies as a result of a high degree of sequence clustering. Time to the most common recent ancestor was relatively short (approximately 1.5 years) and Quetta was identified as the most probable ancestral node location.</p><fig id="pone.0237560.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0237560.g005</object-id><label>Fig 5</label><caption><title>Spatial dispersion of HIV-1 subtype A1 among people who inject drugs in Pakistan.</title><p>Arrows between cities represent the number of HIV-1 migration events inferred using a MCMC structured coalescent approach with MultiTypeTree as implemented in BEAST2. Arrow colors reflect the number of HIV-1 migration events between cities according to the legend at the bottom right corner. This map was created using ESRI ArcMap software version 10.5., using open source data from the Global Administrative Areas version 2.8 (<ext-link ext-link-type="uri" xlink:href="https://gadm.org/data.html">https://gadm.org/data.html</ext-link>).</p></caption><graphic xlink:href="pone.0237560.g005"/></fig><table-wrap id="pone.0237560.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0237560.t002</object-id><label>Table 2</label><caption><title>Inferred HIV-1 subtype A1 migration between cities.</title></caption><alternatives><graphic id="pone.0237560.t002g" xlink:href="pone.0237560.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Migration direction</th><th align="left" rowspan="1" colspan="1">Mean number of ancestral migration events (events [n =] from city <italic>x</italic> to city <italic>y</italic>)</th><th align="left" rowspan="1" colspan="1">Mean number of ancestral migration events standard deviation (&#x000b1; events [n =] from city <italic>x</italic> to city <italic>y</italic>)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Hyderabad &#x02192; Karachi</td><td align="char" char="." rowspan="1" colspan="1">4.32</td><td align="char" char="." rowspan="1" colspan="1">5.32</td></tr><tr><td align="left" rowspan="1" colspan="1">Hyderabad &#x02192; Larkana</td><td align="char" char="." rowspan="1" colspan="1">13.22</td><td align="char" char="." rowspan="1" colspan="1">16.14</td></tr><tr><td align="left" rowspan="1" colspan="1">Hyderabad &#x02192; Peshawar</td><td align="char" char="." rowspan="1" colspan="1">1.00</td><td align="char" char="." rowspan="1" colspan="1">1.27</td></tr><tr><td align="left" rowspan="1" colspan="1">Hyderabad &#x02192; Quetta</td><td align="char" char="." rowspan="1" colspan="1">25.67</td><td align="char" char="." rowspan="1" colspan="1">16.86</td></tr><tr><td align="left" rowspan="1" colspan="1">Karachi &#x02192; Hyderabad</td><td align="char" char="." rowspan="1" colspan="1">8.35</td><td align="char" char="." rowspan="1" colspan="1">11.02</td></tr><tr><td align="left" rowspan="1" colspan="1">Karachi &#x02192; Larkana</td><td align="char" char="." rowspan="1" colspan="1">36.60</td><td align="char" char="." rowspan="1" colspan="1">24.08</td></tr><tr><td align="left" rowspan="1" colspan="1">Karachi &#x02192; Peshawar</td><td align="char" char="." rowspan="1" colspan="1">1.68</td><td align="char" char="." rowspan="1" colspan="1">1.63</td></tr><tr><td align="left" rowspan="1" colspan="1">Karachi &#x02192; Quetta</td><td align="char" char="." rowspan="1" colspan="1">24.46</td><td align="char" char="." rowspan="1" colspan="1">22.12</td></tr><tr><td align="left" rowspan="1" colspan="1">Larkana &#x02192; Hyderabad</td><td align="char" char="." rowspan="1" colspan="1">6.11</td><td align="char" char="." rowspan="1" colspan="1">7.67</td></tr><tr><td align="left" rowspan="1" colspan="1">Larkana &#x02192; Karachi</td><td align="char" char="." rowspan="1" colspan="1">5.58</td><td align="char" char="." rowspan="1" colspan="1">6.81</td></tr><tr><td align="left" rowspan="1" colspan="1">Larkana &#x02192; Peshawar</td><td align="char" char="." rowspan="1" colspan="1">1.31</td><td align="char" char="." rowspan="1" colspan="1">1.51</td></tr><tr><td align="left" rowspan="1" colspan="1">Larkana &#x02192; Quetta</td><td align="char" char="." rowspan="1" colspan="1">58.66</td><td align="char" char="." rowspan="1" colspan="1">24.78</td></tr><tr><td align="left" rowspan="1" colspan="1">Peshawar &#x02192; Hyderabad</td><td align="char" char="." rowspan="1" colspan="1">2.64</td><td align="char" char="." rowspan="1" colspan="1">2.55</td></tr><tr><td align="left" rowspan="1" colspan="1">Peshawar &#x02192; Karachi</td><td align="char" char="." rowspan="1" colspan="1">2.80</td><td align="char" char="." rowspan="1" colspan="1">2.57</td></tr><tr><td align="left" rowspan="1" colspan="1">Peshawar &#x02192; Larkana</td><td align="char" char="." rowspan="1" colspan="1">4.17</td><td align="char" char="." rowspan="1" colspan="1">3.26</td></tr><tr><td align="left" rowspan="1" colspan="1">Peshawar &#x02192; Quetta</td><td align="char" char="." rowspan="1" colspan="1">6.84</td><td align="char" char="." rowspan="1" colspan="1">3.86</td></tr><tr><td align="left" rowspan="1" colspan="1">Quetta &#x02192; Hyderabad</td><td align="char" char="." rowspan="1" colspan="1">3.29</td><td align="char" char="." rowspan="1" colspan="1">3.13</td></tr><tr><td align="left" rowspan="1" colspan="1">Quetta &#x02192; Karachi</td><td align="char" char="." rowspan="1" colspan="1">3.15</td><td align="char" char="." rowspan="1" colspan="1">2.99</td></tr><tr><td align="left" rowspan="1" colspan="1">Quetta &#x02192; Larkana</td><td align="char" char="." rowspan="1" colspan="1">5.62</td><td align="char" char="." rowspan="1" colspan="1">5.15</td></tr><tr><td align="left" rowspan="1" colspan="1">Quetta &#x02192; Peshawar</td><td align="char" char="." rowspan="1" colspan="1">1.16</td><td align="char" char="." rowspan="1" colspan="1">1.33</td></tr></tbody></table></alternatives></table-wrap></sec></sec><sec sec-type="conclusions" id="sec007"><title>Discussion</title><p>Pakistan is currently facing a concentrated HIV-1 epidemic among PWID in multiple cities including Karachi, Hyderabad, Larkana, Quetta and Peshawar despite interventions, such as syringe and needle exchange programs [<xref rid="pone.0237560.ref001" ref-type="bibr">1</xref>]. Earlier phylogenetic studies reported that the HIV-1 epidemic may have been the result of the transmission of a founding subtype A1 virus originating in the 1990s [<xref rid="pone.0237560.ref007" ref-type="bibr">7</xref>]. Our study indicates that this is no longer the case since we observed greater subtype heterogeneity among HIV-1 positive PWID especially in cities such as Karachi. Although subtype A1 is still the dominant circulating strain in Pakistan, greater subtype heterogeneity may be indicative of overlapping sexual and/or drug injecting networks between PWID and other high-risk populations. Existing behavioural data [<xref rid="pone.0237560.ref013" ref-type="bibr">13</xref>] suggest significant sexual and/or drug injection networking between PWID and female sex workers (FSW), hijra sex workers (HSW), and male sex workers (MSW) as well as Afghan refugees residing in Pakistan [<xref rid="pone.0237560.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0237560.ref015" ref-type="bibr">15</xref>]. Phylogenetic analysis of HIV-1 <italic>gag</italic> gene sequences [<xref rid="pone.0237560.ref014" ref-type="bibr">14</xref>] showed that the HIV-1 epidemic in Pakistani MSM is represented by HIV-1 subtypes A, G, CRF01_AE and CRF02_AG while these subtypes in addition to CRF35_AD can be found circulating among HIV-1 positive Afghan refugees living in Karachi [<xref rid="pone.0237560.ref015" ref-type="bibr">15</xref>]. It would not be unexpected that extremely high risk injecting reported earlier [<xref rid="pone.0237560.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0237560.ref013" ref-type="bibr">13</xref>], in an environment of increasing HIV-1 prevalence, could contribute to frequent infection of a single individual with multiple subtypes of HIV-1 leading to the generation of unique recombinant forms. A unique method of assisted injection, locally referred to as &#x0201c;scale&#x0201d;, was first reported among PWID in the city of Sargodha in 2009 [<xref rid="pone.0237560.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0237560.ref005" ref-type="bibr">5</xref>]. This practice involves collecting blood-drug mixtures (&#x0201c;scale&#x0201d;) as payment for professional injection services by double-pumping syringes. The &#x0201c;scale&#x0201d; is then either sold to another client or used by the injector. Recently, Chen <italic>et al</italic>. [<xref rid="pone.0237560.ref010" ref-type="bibr">10</xref>] reported on unique CRF02_AG/A1 recombinants, indicating ongoing recombination between locally transmitted CRF02_AG and A1 strains, suggesting that these unique recombinants may become major epidemic strains in Pakistan. It is likely that we underestimated the proportion of recombinant HIV-1 sequences in our population given we only sequenced a portion of the HIV-1 <italic>pol</italic> gene. More extensive, whole genome-based sequence analysis would be required to resolve the potential HIV-1 recombination events among Pakistani PWID.</p><p>Drug injecting behaviours vary between cities, however unsafe injection practices, large injection networks and the use of professional injectors are common among PWID in Pakistan [<xref rid="pone.0237560.ref005" ref-type="bibr">5</xref>]. Therefore, it is not surprising that nearly three quarters of the HIV-1 <italic>pol</italic> sequences from this study are incorporated into HIV-1 phylogenetic transmission clusters. Seeking help injecting drugs from professional injectors has previously been identified as a strong correlate of HIV-1 infection [<xref rid="pone.0237560.ref005" ref-type="bibr">5</xref>]. At the time of DBS collection, professional injectors were being employed as peer support workers in a number of the cities involved in this study (personal communications with the National AIDS Control Program). Our observation that the odds of clustering was 10.1% less among individuals who regularly sought assistance in injecting drugs supports the utility of this intervention at limiting onward HIV-1 transmission among PWID (manuscript in preparation). Consistent with this observation, one of the largest clusters we identified (n = 52) mainly consisted of individuals sampled in Peshawar (51 of 52) who did not seek help injecting drugs from professional injectors. At present, it is unclear if professional injectors have been employed as peer support workers in Peshawar, but our results would suggest that there may be other unidentified epidemic drivers in this particular city. Alternatively, it may indicate that some study participants did not understand the concept of sharing, did not understand questions pertaining to high risk injecting behaviors, or were unwilling to admit participation in such behaviors.</p><p>Currently, Afghanistan produces approximately 80% of the world&#x02019;s heroin supply [<xref rid="pone.0237560.ref030" ref-type="bibr">30</xref>]. Most of the heroin is trafficked through Pakistan before reaching its final destination in Europe, the Russian Federation and Asia [<xref rid="pone.0237560.ref004" ref-type="bibr">4</xref>]. As such, local consumption markets have been established mainly positioned along important regional trafficking routes. Once inside Pakistan, a significant amount of heroin is trafficked south along main roads and railways southward to Karachi [<xref rid="pone.0237560.ref004" ref-type="bibr">4</xref>]. Concurrently, acetic anhydride&#x02013;a crucial precursor chemical for the synthesis of opium into heroin&#x02013;is trafficked into Afghanistan allegedly along the same trafficking routes, albeit in the northward direction [<xref rid="pone.0237560.ref016" ref-type="bibr">16</xref>]. Acetic anhydride importation is prohibited in Afghanistan therefore the precursor needs to be smuggled into the country&#x02013;primarily via Pakistan. Even though the earliest documented cases of HIV-1 infection were reported in Karachi [<xref rid="pone.0237560.ref017" ref-type="bibr">17</xref>], the first outbreak reported among PWID was observed approximately 500 km to the North in Larkana [<xref rid="pone.0237560.ref018" ref-type="bibr">18</xref>]. At the time, Shah <italic>et al</italic>. (2004) noted an increase in injection drug use and indicated that Larkana had become a &#x0201c;hub&#x0201d; of drug use activities, attracting users from all parts of the country. Shortly thereafter, (&#x02264; 2 years) the epidemic spread to multiple cities, solidifying Pakistan&#x02019;s concentrated epidemic among PWID (<ext-link ext-link-type="uri" xlink:href="http://www.nacp.gov.pk/whatwedo/surveillance.html">www.nacp.gov.pk/whatwedo/surveillance.html</ext-link>) [<xref rid="pone.0237560.ref002" ref-type="bibr">2</xref>, <xref rid="pone.0237560.ref019" ref-type="bibr">19</xref>]. The relatively short time to the most common recent ancestor observed in our analysis is consistent with rapid rises in HIV-1 infection among PWID in Pakistan. Taken altogether, the flow of opioid trafficking and epidemiological data are consistent with the observed HIV-1 migration patterns based on our molecular findings that place Larkana at the center of the PWID HIV-1 epidemic in Pakistan. Yet, we interpret these results with caution since most ancestral nodes had low posterior probability values. Several cities facing a concentrated HIV-1 epidemic [<xref rid="pone.0237560.ref001" ref-type="bibr">1</xref>] were not sampled during this study, so HIV-1 migration patterns could change with the addition of new/different sampling locations. Furthermore, it would also be important to consider internal population displacement (IDP) due to economic hardship, natural disasters and conflict (<ext-link ext-link-type="uri" xlink:href="http://hrcp-web.org/hrcpweb/wp-content/pdf/ff/22.pdf">http://hrcp-web.org/hrcpweb/wp-content/pdf/ff/22.pdf</ext-link>) [<xref rid="pone.0237560.ref020" ref-type="bibr">20</xref>] as possible explanations for the observed migration patterns.</p><p>Initially, high quality powder heroin was abundant in Pakistan with smoking being the primary means of consumption [<xref rid="pone.0237560.ref020" ref-type="bibr">20</xref>]. However, recent conflict in neighboring Afghanistan may have directly or indirectly facilitated transitions to injection drug use [<xref rid="pone.0237560.ref020" ref-type="bibr">20</xref>] in Pakistan by causing fluctuations in prices, purity and availability of heroin. It is widely known that the Taliban relies on heroin production and trafficking to fund operations. Consistent with this, trends in opium cultivation over the last decade have generally reflected conflict intensity in the area [<xref rid="pone.0237560.ref021" ref-type="bibr">21</xref>]. Based on our Bayesian skyline plot analysis, changes in HIV-1 effective population size estimates among PWID in Pakistan correspond with fluctuations in opium cultivation in Afghanistan [<xref rid="pone.0237560.ref012" ref-type="bibr">12</xref>]. More specifically, both spikes in estimates of HIV-1 effective population sizes coincided with increases in opium poppy cultivation. This observation suggests that the transmission of HIV-1 among PWID in Pakistan is associated with local trends in opium trafficking&#x02013;influenced by conflict&#x02013;and exacerbated by unsafe injection practices. Nevertheless, our analysis was limited to sequences from samples collected in 2005, 2007 and 2014 so we cannot rule out other possibilities that could explain instances of HIV-1 effective population growth like contractions of HIV/AIDS programs caused by the reallocation of funds to disaster relief efforts (i.e. major flooding) over the last decade [<xref rid="pone.0237560.ref022" ref-type="bibr">22</xref>].</p></sec><sec sec-type="conclusions" id="sec008"><title>Conclusions</title><p>In summary, our results suggest that the current epidemic among PWID is no longer an onward transmission of a limited number of A1 subtype founder viruses as reported previously. The greater subtype heterogeneity would be consistent with sexual and/or drug injecting networks between PWID and other most-at-risk populations reported by others. Although it is evident that unsafe injection behaviors played a significant role in driving the rise in HIV-1 prevalence among PWID, local trends in illicit opioid trafficking may have influenced injection behaviors and facilitated HIV-1 transmission as a result. Based on both epidemiologic and molecular findings, the HIV-1 epidemic does not appear to have simply spread northward from Karachi but that Larkana may have had a more significant role in the amplifying of the PWID HIV-1 epidemic. Since the transmission of HIV-1 between PWID appears to be associated with trends in drug trafficking, it is possible that intimate knowledge of the drug trade may help anticipate future HIV-1 outbreaks. It will also be interesting to compare the phylogenetic data described above with that collected from other urban centers to determine if our observations are consistent in other PWID communities throughout Pakistan.</p></sec><sec sec-type="materials|methods" id="sec009"><title>Materials and methods</title><sec id="sec010"><title>Study participants and biological sample collection</title><p>PWID were recruited from the Pakistani cities of Karachi (n = 300), Larkana (n = 300), Peshawar (n = 253), Quetta (n = 300) and Hyderabad (n = 300) from August to December, 2014. A detailed mapping of size, geography and operation typology of the PWID population was undertaken prior to the actual survey to ensure that the collected sample accurately reflects the study population. Mapping methodology is described in detail elsewhere [<xref rid="pone.0237560.ref023" ref-type="bibr">23</xref>]. Field teams recruited study participants at PWID hotspots using multiple techniques such as multi-stage cluster sampling, snowball sampling, and time location cluster sampling [<xref rid="pone.0237560.ref024" ref-type="bibr">24</xref>]. After obtaining informed consent, participants were interviewed using a structured questionnaire to collect information pertaining to sociodemographics, drug use practices, social networks, sexual behavior, and utilization of services for HIV testing and care. A summary of the baseline sociodemographic characteristics of the study population is provided in <xref rid="pone.0237560.t003" ref-type="table">Table 3</xref>. Participants were also asked if they were currently receiving antiretrovirals (ARVs). Among those who answered (n = 49), only 4 individuals indicated that they were receiving ARVs. At the completion of the interview, DBS specimens were collected by the standard finger prick method using a self-retracting safety lancet device. After saturating each of the five spots printed on Whatman 903 filter paper cards (GE Healthcare Life Sciences, Mississauga, ON), DBS were air dried for a minimum of 3 hours at ambient temperature prior to storage at room temperature in sealed gas-impermeable bags containing desiccant pouches [<xref rid="pone.0237560.ref025" ref-type="bibr">25</xref>].</p><table-wrap id="pone.0237560.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0237560.t003</object-id><label>Table 3</label><caption><title>Baseline sociodemographic characteristics of PWID recruited from the Pakistani cities of Karachi, Larkana, Peshawar, Quetta and Hyderabad.</title></caption><alternatives><graphic id="pone.0237560.t003g" xlink:href="pone.0237560.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">HIV-1 negative</th><th align="center" rowspan="1" colspan="1">HIV-1 positive</th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">N = 1,086</th><th align="center" rowspan="1" colspan="1">N = 367</th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">% (N)</th><th align="center" rowspan="1" colspan="1">% (N)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age category</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;20&#x02013;24</td><td align="left" rowspan="1" colspan="1">18.8 (204)</td><td align="left" rowspan="1" colspan="1">24.0 (88)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;25&#x02013;29</td><td align="left" rowspan="1" colspan="1">26.6 (289)</td><td align="left" rowspan="1" colspan="1">33.2 (122)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;30&#x02013;34</td><td align="left" rowspan="1" colspan="1">18.5 (201)</td><td align="left" rowspan="1" colspan="1">18.8 (69)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;35&#x02013;39</td><td align="left" rowspan="1" colspan="1">13.9 (151)</td><td align="left" rowspan="1" colspan="1">9.3 (34)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02267;40</td><td align="left" rowspan="1" colspan="1">19.3 (210)</td><td align="left" rowspan="1" colspan="1">9.8 (36)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x0003c;20</td><td align="left" rowspan="1" colspan="1">2.9 (31)</td><td align="left" rowspan="1" colspan="1">4.9 (18)</td></tr><tr><td align="left" rowspan="1" colspan="1">Gender identity</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Female</td><td align="left" rowspan="1" colspan="1">0.6 (7)</td><td align="left" rowspan="1" colspan="1">0.8 (3)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Male</td><td align="left" rowspan="1" colspan="1">99.0 (1,075)</td><td align="left" rowspan="1" colspan="1">99.2 (364)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Transgender</td><td align="left" rowspan="1" colspan="1">0.4 (4)</td><td align="left" rowspan="1" colspan="1">0 (0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Years of education</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;1&#x02013;6 years</td><td align="left" rowspan="1" colspan="1">25.1 (268)</td><td align="left" rowspan="1" colspan="1">24.8 (90)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02267;7 years</td><td align="left" rowspan="1" colspan="1">21.6 (231)</td><td align="left" rowspan="1" colspan="1">22.9 (83)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;None</td><td align="left" rowspan="1" colspan="1">45.9 (490)</td><td align="left" rowspan="1" colspan="1">43.8 (159)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Quranic</td><td align="left" rowspan="1" colspan="1">7.4 (79)</td><td align="left" rowspan="1" colspan="1">8.5 (31)</td></tr><tr><td align="left" rowspan="1" colspan="1">Marital status</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Married</td><td align="left" rowspan="1" colspan="1">35.2 (379)</td><td align="left" rowspan="1" colspan="1">32.1 (117)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Seperated/divorced/widowed</td><td align="left" rowspan="1" colspan="1">16.2 (174)</td><td align="left" rowspan="1" colspan="1">11.2 (41)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Unmarried</td><td align="left" rowspan="1" colspan="1">48.7 (524)</td><td align="left" rowspan="1" colspan="1">56.7 (207)</td></tr><tr><td align="left" rowspan="1" colspan="1">Slept in their own home</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No</td><td align="left" rowspan="1" colspan="1">31.5 (342)</td><td align="left" rowspan="1" colspan="1">30.3 (111)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td align="left" rowspan="1" colspan="1">68.5 (744)</td><td align="left" rowspan="1" colspan="1">69.8 (256)</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec011"><title>Ethics statement</title><p>Ethical approval was obtained from the Health Research Ethics Board at the University of Manitoba [HS15691(H2012:294)], Canada and BRIDGE Consultants Foundation, Pakistan. Informed consent was obtained verbally from study participants for the behavioural survey and biological sampling components of this study. Verbal consent was chosen due to varying levels of literacy among study participants and as an additional measure of protecting their identities and documented by a member of the data collection team.</p></sec><sec id="sec012"><title>Serological testing</title><p>All DBS specimen cards were screened for HIV-1 with the AVIOQ HIV-1 Microelisa System (Avioq Inc., Durham, NC) according to the manufacturer&#x02019;s instructions.</p></sec><sec id="sec013"><title>Isolation of nucleic acids, amplification and sequencing</title><p>A routine, in-house HIV-1 drug resistance mutation genotyping assay was used to sequence a portion of the <italic>pol</italic> open reading frame (nt 2,074&#x02013;3,334 on HXB2, K03455). Internal validation (results not shown) determined that the lower limit of detection of the assay on DBS is approximately &#x02265;1,000 HIV-1 copies/mL. Briefly, total nucleic acid was isolated from a single DBS (approximately 75 &#x003bc;L of whole blood) using an automated, magnetic silica-based, NucliSENS easyMAG instrument (bioM&#x000e9;rieux, St-Laurent, QC) according to the manufacturer&#x02019;s specific B protocol (version 2.0.1). Each DBS were lysed for 1 hour at room temperature with gentle agitation in 2 mL of NucliSENS lysis buffer (bioM&#x000e9;rieux). Purified nucleic acid was eluted in 50 &#x003bc;L of NucliSENS extraction buffer 3 (bioM&#x000e9;rieux) and stored immediately at -80&#x000b0;C. The <italic>protease</italic> (PROT) and partial <italic>reverse transcriptase</italic> (RT) genes were amplified in two separate fragments by reverse transcriptase PCR (<xref ref-type="supplementary-material" rid="pone.0237560.s004">S3</xref>&#x02013;<xref ref-type="supplementary-material" rid="pone.0237560.s006">S5</xref> Tables) followed by nested PCR (<xref ref-type="supplementary-material" rid="pone.0237560.s007">S6</xref>&#x02013;<xref ref-type="supplementary-material" rid="pone.0237560.s009">S8</xref> Tables) with the help of the SuperScript III one-step RT-PCR system (ThermoFisher Scientific, Burlington, ON) and AmpliTaq Gold DNA polymerase (ThermoFisher Scientific) respectively. Sanger sequencing was performed using the BigDye Terminator v3.1 cycle sequencing kit (ThermoFisher Scientific) with nested PCR and sequencing primers (<xref ref-type="supplementary-material" rid="pone.0237560.s010">S9 Table</xref>). Sequence analysis and contig assembly were performed using RECall to standardize sequence interpretation [<xref rid="pone.0237560.ref026" ref-type="bibr">26</xref>]. We also included PWID HIV-1 <italic>pol</italic> sequences from Karachi (accession no. JQ011747, JQ011748, and JQ011750&#x02014;JQ011780) and Sargodha (accession no. JQ011625&#x02014;JQ011628, JQ011630, JQ011632, JQ011634, JQ011637, JQ011639, JQ011641, JQ011642, JQ011652, JQ011654, JQ011655, JQ011656, JQ011662, JQ011663, JQ011664, JQ011670, JQ011673, JQ011675, JQ011676, JQ011678, JQ011680, JQ011681, JQ011687, JQ011688, JQ011690, JQ011691, JQ011695, JQ011699, JQ011700, JQ011702, JQ011704, JQ011709, JQ011710, JQ011714, JQ011720, JQ011721, JQ011726, JQ011729, JQ011732, JQ011733, JQ011742, and JQ011743) reported during outbreaks in 2005 and 2007, respectively.</p></sec><sec id="sec014"><title>Subtyping and phylogenetic cluster analysis</title><p>PWID HIV-1 <italic>pol</italic> sequences were aligned, visually inspected and manually edited in MEGA v7 [<xref rid="pone.0237560.ref027" ref-type="bibr">27</xref>] as required. Codons associated with major drug-resistance mutations were not removed from sequence alignments because participants were most likely antiretroviral treatment (ART)-na&#x000ef;ve due to poor coverage of HIV/AIDS treatment programs. [<xref rid="pone.0237560.ref028" ref-type="bibr">28</xref>] Each PWID specimen was subtyped with the REGA HIV-1 automated subtyping tool v3 [<xref rid="pone.0237560.ref029" ref-type="bibr">29</xref>] and COMET [<xref rid="pone.0237560.ref030" ref-type="bibr">30</xref>]. In the event of discordant results, SCUEAL [<xref rid="pone.0237560.ref031" ref-type="bibr">31</xref>] was used as a tiebreaker.</p><p>For phylogenetic cluster analysis, reference and background sequences were obtained from the Los Alamos HIV database (<ext-link ext-link-type="uri" xlink:href="http://www.hiv.lanl.gov/">http://www.hiv.lanl.gov/</ext-link>). Furthermore, the top 10 BLASTn hits for each PWID HIV-1 sequence were also included as background sequences. Duplicate sequences were removed from the alignment. Maximum likelihood (ML) trees were reconstructed with IQ-TREE v1.4.4 [<xref rid="pone.0237560.ref032" ref-type="bibr">32</xref>], using the best-fitting substitution model selected automatically by IQ-TREE. Reliability of the tree topologies was assessed by ultra-fast bootstrap [<xref rid="pone.0237560.ref033" ref-type="bibr">33</xref>] re-sampling (100,000 replicates). Monophyletic clades were identified with ClusterPicker v1.2.3 using 90% bootstrap support, a genetic distance cutoff of 4.5% and a large cluster threshold of 5 [<xref rid="pone.0237560.ref034" ref-type="bibr">34</xref>]. Trees were visualized and annotated in FigTree v1.4.3 (<ext-link ext-link-type="uri" xlink:href="http://tree.bio.ed.ac.uk/software/figtree/">http://tree.bio.ed.ac.uk/software/figtree/</ext-link>). Odds of PWID sequences clustering were calculated using odds ratios in Epi Info for Windows v7 (<ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/epiinfo/index.html">https://www.cdc.gov/epiinfo/index.html</ext-link>).</p><p>Phylogenetic clusters were inferred using a second method based on tip-to-tip (patristic) distance between sequences measured on phylogenetic trees [<xref rid="pone.0237560.ref035" ref-type="bibr">35</xref>]. Briefly, HIV-1 pol sequences from all participants were aligned using MAFFT v7.2.2.1 [<xref rid="pone.0237560.ref036" ref-type="bibr">36</xref>], visually inspected using AliView v.1.15 [<xref rid="pone.0237560.ref037" ref-type="bibr">37</xref>], and codons associated with major drug-resistance mutations were removed. A distribution of 100 phylogenies was inferred using a General Time Reversible (GTR) nucleotide substitution model and FastTree2 v2.1.8 [<xref rid="pone.0237560.ref038" ref-type="bibr">38</xref>]. Phylogenetic clusters of 5 or more participants consistent across all 100 trees were identified using a tip-to-tip (patristic) distance cutoff of &#x0003c;0.02 substitutions per site. Clusters were visualized and annotated in Cytoscape v3.7.2 (<ext-link ext-link-type="uri" xlink:href="https://cytoscape.org/">https://cytoscape.org/</ext-link>).</p></sec><sec id="sec015"><title>Phylodynamic analysis</title><p>Effective population size estimates (Bayesian skyline plot analysis) were inferred using a Bayesian Markov Chain Monte Carlo (MCMC) analysis of time-stamped taxa using BEAST v1.10.4 [<xref rid="pone.0237560.ref039" ref-type="bibr">39</xref>] under a general time reversible (GTR) substitution model (4 gamma categories), a strict molecular clock model set to a rate of 2.5 x 10<sup>&#x02212;3</sup> substitutions/site/year (1.1, 4.0; 95% confidence interval) [<xref rid="pone.0237560.ref040" ref-type="bibr">40</xref>], a coalescent Bayesian Skyline tree prior [<xref rid="pone.0237560.ref041" ref-type="bibr">41</xref>] and chain lengths of 1&#x02013;9 x 10<sup>8</sup> sampled to generate 10,000 trees. Different demographic models were compared by marginal likelihood estimation (i.e. path sampling/stepping-stone sampling) as implemented in BEAST v1.10.4 [<xref rid="pone.0237560.ref042" ref-type="bibr">42</xref>]. The coalescent Bayesian Skyline tree prior had the highest log marginal likelihood (-13,303.7) compared to the coalescent constant size (-13,500.2), coalescent exponential size (-13,360.6), coalescent logistic growth (-13,351.6), and coalescent Bayesian SkyGrid (-13,386.0) tree priors. Convergence of each run was assessed using Tracer v1.7.1 to ensure that effective sample sizes (ESS) &#x0003e;200 were obtained for all statistics and that acceptable mixing was achieved [<xref rid="pone.0237560.ref043" ref-type="bibr">43</xref>]. Effective population size estimates of HIV-1 were limited to subtype A1 sequences from this study and databases sequences (listed above) with injection drug use as a known risk behavior. HIV-1 subtype A1 sequences were chosen according to the subtyping approach described above. Any potential recombinant HIV-1 subtype A1 sequences were identified with Recombination Detection Program (RDP) v4.97 [<xref rid="pone.0237560.ref044" ref-type="bibr">44</xref>] and omitted from HIV-1 effective population size estimates (<xref ref-type="supplementary-material" rid="pone.0237560.s011">S10 Table</xref>). The relationship between effective HIV-1 population size estimates and opium cultivation was modeled by linear regression in SPSS (IBM, Armonk, NY).</p><p>HIV-1 migration was inferred using a MCMC structured coalescent approach with MultiTypeTree [<xref rid="pone.0237560.ref045" ref-type="bibr">45</xref>] as implemented in BEAST2 v2.4.5 [<xref rid="pone.0237560.ref046" ref-type="bibr">46</xref>] under a GTR substitution model (4 gamma categories), a strict molecular clock model set to a rate of 1.52 x 10<sup>&#x02212;3</sup> substitutions/site/year with a lognormal distribution, and chain lengths &#x0003e;5 x 10<sup>8</sup> sampled to generate 10,000 trees. The strict molecular clock rate represents the posterior from effective population size estimates described above. HIV-1 migration is measured in terms of the number of ancestral migrations events from city <italic>x</italic> to city <italic>y</italic>. Restrictions were set on population size (log<sub>10</sub>) for each city based on mapping exercises carried out in Pakistan [<xref rid="pone.0237560.ref001" ref-type="bibr">1</xref>]. Convergence of each run was assessed using Tracer 1.7.1 to ensure that ESS &#x0003e;200 were obtained for all statistics and that acceptable mixing was achieved [<xref rid="pone.0237560.ref043" ref-type="bibr">43</xref>]. Structured coalescent analysis was limited to HIV-1 subtype A1 sequences from our study given the computational limitations for reliable ancestral migration estimates [<xref rid="pone.0237560.ref045" ref-type="bibr">45</xref>]. Older database sequences (e.g. from Karachi and Sargodha) were omitted from this analysis to provide a contemporary snapshot of HIV-1 migration. PWID in Pakistan are a highly mobile population [<xref rid="pone.0237560.ref001" ref-type="bibr">1</xref>] therefore, including older database sequences may not be representative of the most current HIV-1 migration patterns. HIV-1 subtype A1 sequences were chosen according to the subtyping approach described above. Any potential recombinant HIV-1 subtype A1 sequences were identified with RDP v4.97 [<xref rid="pone.0237560.ref044" ref-type="bibr">44</xref>] and omitted from the structured coalescent analysis (<xref ref-type="supplementary-material" rid="pone.0237560.s011">S10 Table</xref>). All XML files are available upon request.</p></sec></sec><sec sec-type="supplementary-material" id="sec016"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0237560.s001"><label>S1 Fig</label><caption><title>The maximum clade credibility (MCC) tree, summarizing the posterior tree distribution from the MultiTypeTree analysis.</title><p>Nodes have been annotated with the type posterior probability (below) and associated dates (above). Only support values greater than 70 are displayed. The 95% highest posterior density (HPD) intervals of the dates associated to the root and select nodes are located within parentheses. The type posterior probability is defined as the posterior probability of the most probable location. Years are displayed as labels on the x-axis.</p><p>(TIFF)</p></caption><media xlink:href="pone.0237560.s001.tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0237560.s002"><label>S1 Table</label><caption><title>HIV-1 subtype assignment.</title><p>(DOCX)</p></caption><media xlink:href="pone.0237560.s002.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0237560.s003"><label>S2 Table</label><caption><title>HIV-1 sequences included in the phylogenetic cluster analysis.</title><p>(DOCX)</p></caption><media xlink:href="pone.0237560.s003.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0237560.s004"><label>S3 Table</label><caption><title>Description of RT-PCR primers for in-house HIV-1 drug resistance mutation genotyping.</title><p>(DOCX)</p></caption><media xlink:href="pone.0237560.s004.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0237560.s005"><label>S4 Table</label><caption><title>Master mix preparation for the reverse transcription and subsequent amplification (RT-PCR) of HIV-1 PROT and partial RT genes.</title><p>(DOCX)</p></caption><media xlink:href="pone.0237560.s005.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0237560.s006"><label>S5 Table</label><caption><title>Thermal cycling conditions for RT-PCR.</title><p>(DOCX)</p></caption><media xlink:href="pone.0237560.s006.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0237560.s007"><label>S6 Table</label><caption><title>Description of nested PCR primers for in-house HIV-1 drug resistance mutation genotyping.</title><p>(DOCX)</p></caption><media xlink:href="pone.0237560.s007.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0237560.s008"><label>S7 Table</label><caption><title>Master mix preparation for the second round (nested PCR) of HIV-1 PROT and partial RT gene amplification.</title><p>(DOCX)</p></caption><media xlink:href="pone.0237560.s008.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0237560.s009"><label>S8 Table</label><caption><title>Thermal cycling conditions for nested PCR.</title><p>(DOCX)</p></caption><media xlink:href="pone.0237560.s009.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0237560.s010"><label>S9 Table</label><caption><title>Additional HIV-1 PROT and partial RT sequencing primers.</title><p>(DOCX)</p></caption><media xlink:href="pone.0237560.s010.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0237560.s011"><label>S10 Table</label><caption><title>Potential recombinant HIV-1 subtype A1 sequences identified with RDP v4.97.</title><p>(DOCX)</p></caption><media xlink:href="pone.0237560.s011.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank the surveillance team for their efforts in mapping, data collection, specimen collection and data entry. We also thank the participants who took part in the surveys for their time and participation. We thank Kiana Kadivar (National HIV and Retrovirology Laboratories) for her initial assistance with coordinating serological testing and Jesse Knight (St. Michael&#x02019;s Hospital) for his support preparing figures.</p></ack><ref-list><title>References</title><ref id="pone.0237560.ref001"><label>1</label><mixed-citation publication-type="other">National AIDS Control Program. HIV Second Generation Surveillance in Pakistan: National Report Round IV. Chak Shahzad, Islamabad, Pakistan: National Institute of Health, 2011.</mixed-citation></ref><ref id="pone.0237560.ref002"><label>2</label><mixed-citation publication-type="other">National AIDS Control Program. HIV Second Generation Surveillance in Pakistan: National Report Round II. Chak Shehzad, Islamabad, Pakistan: Ministry of National Health Services, Regulation &#x00026; Coordination, Government of Pakistan, 2006/2007.</mixed-citation></ref><ref id="pone.0237560.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Emmanuel</surname><given-names>F</given-names></name>, <name><surname>Archibald</surname><given-names>C</given-names></name>, <name><surname>Razaque</surname><given-names>A</given-names></name>, <name><surname>Sandstrom</surname><given-names>P</given-names></name>. <article-title>Factors associated with an explosive HIV epidemic among injecting drug users in Sargodha, Pakistan</article-title>. <source>Journal of acquired immune deficiency syndromes (1999)</source>. <year>2009</year>;<volume>51</volume>(<issue>1</issue>):<fpage>85</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">19289969</pub-id></mixed-citation></ref><ref id="pone.0237560.ref004"><label>4</label><mixed-citation publication-type="other">United Nations Office on Drugs and Crime. World Drug Report. Vienna, Austria: United Nations, 2010.</mixed-citation></ref><ref id="pone.0237560.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>AA</given-names></name>, <name><surname>Awan</surname><given-names>AB</given-names></name>, <name><surname>Qureshi</surname><given-names>SU</given-names></name>, <name><surname>Razaque</surname><given-names>A</given-names></name>, <name><surname>Zafar</surname><given-names>ST</given-names></name>. <article-title>Large sharing networks and unusual injection practices explain the rapid rise in HIV among IDUs in Sargodha, Pakistan</article-title>. <source>Harm Reduct J</source>. <year>2009</year>;<volume>6</volume>:<fpage>13</fpage>
<pub-id pub-id-type="doi">10.1186/1477-7517-6-13</pub-id>
<?supplied-pmid 19558668?><pub-id pub-id-type="pmid">19558668</pub-id></mixed-citation></ref><ref id="pone.0237560.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>AA</given-names></name>, <name><surname>Khan</surname><given-names>A</given-names></name>. <article-title>The HIV Epidemic in Pakistan</article-title>. <source>Journal of Pakistan Medical Association</source>. <year>2010</year>;<volume>60</volume>(<issue>4</issue>):<fpage>300</fpage>&#x02013;<lpage>7</lpage>.</mixed-citation></ref><ref id="pone.0237560.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Rai</surname><given-names>MA</given-names></name>, <name><surname>Nerurkar</surname><given-names>VR</given-names></name>, <name><surname>Khoja</surname><given-names>S</given-names></name>, <name><surname>Khan</surname><given-names>S</given-names></name>, <name><surname>Yanagihara</surname><given-names>R</given-names></name>, <name><surname>Rehman</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Evidence for a "Founder Effect" among HIV-infected injection drug users (IDUs) in Pakistan</article-title>. <source>BMC Infect Dis</source>. <year>2010</year>;<volume>10</volume>:<fpage>7</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2334-10-7</pub-id>
<?supplied-pmid 20064274?><pub-id pub-id-type="pmid">20064274</pub-id></mixed-citation></ref><ref id="pone.0237560.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Monleau</surname><given-names>M</given-names></name>, <name><surname>Butel</surname><given-names>C</given-names></name>, <name><surname>Delaporte</surname><given-names>E</given-names></name>, <name><surname>Boillot</surname><given-names>F</given-names></name>, <name><surname>Peeters</surname><given-names>M</given-names></name>. <article-title>Effect of storage conditions of dried plasma and blood spots on HIV-1 RNA quantification and PCR amplification for drug resistance genotyping</article-title>. <source>The Journal of antimicrobial chemotherapy</source>. <year>2010</year>;<volume>65</volume>(<issue>8</issue>):<fpage>1562</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkq205</pub-id>
<?supplied-pmid 20542904?><pub-id pub-id-type="pmid">20542904</pub-id></mixed-citation></ref><ref id="pone.0237560.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Pirillo</surname><given-names>MF</given-names></name>, <name><surname>Recordon-Pinson</surname><given-names>P</given-names></name>, <name><surname>Andreotti</surname><given-names>M</given-names></name>, <name><surname>Mancini</surname><given-names>MG</given-names></name>, <name><surname>Amici</surname><given-names>R</given-names></name>, <name><surname>Giuliano</surname><given-names>M</given-names></name>. <article-title>Quantification of HIV-RNA from dried blood spots using the Siemens VERSANT HIV-1 RNA (kPCR) assay</article-title>. <source>The Journal of antimicrobial chemotherapy</source>. <year>2011</year>;<volume>66</volume>(<issue>12</issue>):<fpage>2823</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkr383</pub-id>
<?supplied-pmid 21930572?><pub-id pub-id-type="pmid">21930572</pub-id></mixed-citation></ref><ref id="pone.0237560.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>Y</given-names></name>, <name><surname>Hora</surname><given-names>B</given-names></name>, <name><surname>DeMarco</surname><given-names>T</given-names></name>, <name><surname>Shah</surname><given-names>SA</given-names></name>, <name><surname>Ahmed</surname><given-names>M</given-names></name>, <name><surname>Sanchez</surname><given-names>AM</given-names></name>, <etal>et al</etal>
<article-title>Fast dissemination of new HIV-1 CRF02/A1 recombinants in Pakistan</article-title>. <source>PLoS One</source>. <year>2016</year>;<volume>11</volume>(<issue>12</issue>):<fpage>e0167839</fpage> Epub 2016/12/16. <pub-id pub-id-type="doi">10.1371/journal.pone.0167839</pub-id>
<?supplied-pmid 27973597?><pub-id pub-id-type="pmid">27973597</pub-id></mixed-citation></ref><ref id="pone.0237560.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Altschul</surname><given-names>SF</given-names></name>, <name><surname>Gish</surname><given-names>W</given-names></name>, <name><surname>Miller</surname><given-names>W</given-names></name>, <name><surname>Myers</surname><given-names>EW</given-names></name>, <name><surname>Lipman</surname><given-names>DJ</given-names></name>. <article-title>Basic Local Alignment Search Tool</article-title>. <source>Journal of Molecular Biology</source>. <year>1990</year>;<volume>215</volume>:<fpage>403</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-2836(05)80360-2</pub-id>
<?supplied-pmid 2231712?><pub-id pub-id-type="pmid">2231712</pub-id></mixed-citation></ref><ref id="pone.0237560.ref012"><label>12</label><mixed-citation publication-type="other">Crime UNOoDa, Narcotics IRoAMoC. Afghanistan opium survey: Cultivation and production. 2016.</mixed-citation></ref><ref id="pone.0237560.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Archibald</surname><given-names>CP</given-names></name>, <name><surname>Shaw</surname><given-names>SY</given-names></name>, <name><surname>Emmanuel</surname><given-names>F</given-names></name>, <name><surname>Otho</surname><given-names>S</given-names></name>, <name><surname>Reza</surname><given-names>T</given-names></name>, <name><surname>Altaf</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Geographical and temporal variation of injection drug users in Pakistan</article-title>. <source>Sex Transm Infect</source>. <year>2013</year>;<volume>89</volume>
<issue>Suppl 2</issue>:<fpage>ii18</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="pmid">23314301</pub-id></mixed-citation></ref><ref id="pone.0237560.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Khanani</surname><given-names>MR</given-names></name>, <name><surname>Somani</surname><given-names>M</given-names></name>, <name><surname>Rehmani</surname><given-names>SS</given-names></name>, <name><surname>Veras</surname><given-names>NM</given-names></name>, <name><surname>Salemi</surname><given-names>M</given-names></name>, <name><surname>Ali</surname><given-names>SH</given-names></name>. <article-title>The spread of HIV in Pakistan: bridging of the epidemic between populations</article-title>. <source>PLoS One</source>. <year>2011</year>;<volume>6</volume>(<issue>7</issue>):<fpage>e22449</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0022449</pub-id>
<?supplied-pmid 21799857?><pub-id pub-id-type="pmid">21799857</pub-id></mixed-citation></ref><ref id="pone.0237560.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Ansari</surname><given-names>AS</given-names></name>, <name><surname>Khanani</surname><given-names>MR</given-names></name>, <name><surname>Abidi</surname><given-names>SH</given-names></name>, <name><surname>Shah</surname><given-names>F</given-names></name>, <name><surname>Shahid</surname><given-names>A</given-names></name>, <name><surname>Ali</surname><given-names>SH</given-names></name>. <article-title>Patterns of HIV infection among Native and Refugee Afghans</article-title>. <source>AIDS</source>. <year>2011</year>;<volume>25</volume>(<issue>11</issue>):<fpage>1427</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1097/QAD.0b013e32834800e7</pub-id>
<?supplied-pmid 21516026?><pub-id pub-id-type="pmid">21516026</pub-id></mixed-citation></ref><ref id="pone.0237560.ref016"><label>16</label><mixed-citation publication-type="journal"><collab>United Nations Office on Drugs and Crime</collab>. <article-title>Acetic anhydride trafficking to Afghanistan</article-title>. <source>Trends in Organized Crime</source>. <year>2012</year>;<volume>15</volume>(<issue>2&#x02013;3</issue>):<fpage>241</fpage>&#x02013;<lpage>59</lpage>.</mixed-citation></ref><ref id="pone.0237560.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Khanani</surname><given-names>RM</given-names></name>, <name><surname>Hafeez</surname><given-names>A</given-names></name>, <name><surname>Rab</surname><given-names>SM</given-names></name>, <name><surname>Rasheed</surname><given-names>S</given-names></name>. <article-title>Human immunodeficiency virus-associated disorders in Pakistan</article-title>. <source>AIDS Res Hum Retroviruses</source>. <year>1988</year>;<volume>4</volume>(<issue>2</issue>):<fpage>149</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1089/aid.1988.4.149</pub-id>
<?supplied-pmid 3365358?><pub-id pub-id-type="pmid">3365358</pub-id></mixed-citation></ref><ref id="pone.0237560.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Shah</surname><given-names>SA</given-names></name>, <name><surname>Altaf</surname><given-names>A</given-names></name>, <name><surname>Mujeeb</surname><given-names>SA</given-names></name>, <name><surname>Memon</surname><given-names>A</given-names></name>. <article-title>An Outbreak of HIV Infection among injection drug users in a small town in Pakistan: Potential for national implications</article-title>. <source>International Journal of STD &#x00026; AIDS</source>. <year>2004</year>;<volume>15</volume>(<issue>3</issue>):<fpage>209</fpage>.</mixed-citation></ref><ref id="pone.0237560.ref019"><label>19</label><mixed-citation publication-type="other">National AIDS Control Program. HIV second generation surveillance in Pakistan: National report round 1. Chak Shehzad, Islamabad, Pakistan: Ministry of National Health Services, Regulation &#x00026; Coordination, Government of Pakistan, 2005.</mixed-citation></ref><ref id="pone.0237560.ref020"><label>20</label><mixed-citation publication-type="other">Din NU. Internal displacement in Pakistan: Contemporary challenges. New Garden Town, Lahore, Pakistan: Human Rights Commission of Pakistan, 2010.</mixed-citation></ref><ref id="pone.0237560.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Griffin</surname><given-names>N</given-names></name>, <name><surname>Khoshnood</surname><given-names>K</given-names></name>. <article-title>Opium trade, insurgency, and HIV/AIDS in Afghanistan: relationships and regional consequences</article-title>. <source>Asia Pac J Public Health</source>. <year>2010</year>;<volume>22</volume>(<issue>3 Suppl</issue>):<fpage>159S</fpage>&#x02013;<lpage>67S</lpage>. <pub-id pub-id-type="doi">10.1177/1010539510374524</pub-id>
<?supplied-pmid 20566549?><pub-id pub-id-type="pmid">20566549</pub-id></mixed-citation></ref><ref id="pone.0237560.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Emmanuel</surname><given-names>F</given-names></name>, <name><surname>Thompson</surname><given-names>LH</given-names></name>, <name><surname>Salim</surname><given-names>M</given-names></name>, <name><surname>Akhtar</surname><given-names>N</given-names></name>, <name><surname>Reza</surname><given-names>TE</given-names></name>, <name><surname>Hafeez</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>The size and distribution of key populations at greater risk of HIV in Pakistan: implications for resource allocation for scaling up HIV prevention programmes</article-title>. <source>Sex Transm Infect</source>. <year>2013</year>;<volume>89</volume>
<issue>Suppl 2</issue>:<fpage>ii11</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">23843454</pub-id></mixed-citation></ref><ref id="pone.0237560.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Emmanuel</surname><given-names>F</given-names></name>, <name><surname>Blanchard</surname><given-names>JF</given-names></name>, <name><surname>Zaheer</surname><given-names>HA</given-names></name>, <name><surname>Reza</surname><given-names>T</given-names></name>, <name><surname>Holte-McKenzie</surname><given-names>M</given-names></name>. <article-title>The HIV/AIDS surveillance project mapping approach: An innovative approach for mapping and size estimation for groups at a higher risk of HIV in Pakistan</article-title>. <source>AIDS</source>. <year>2010</year>;<volume>24</volume>:<fpage>S77</fpage>&#x02013;<lpage>S84</lpage>. <pub-id pub-id-type="doi">10.1097/01.aids.0000386737.25296.c4</pub-id>
<?supplied-pmid 20610953?><pub-id pub-id-type="pmid">20610953</pub-id></mixed-citation></ref><ref id="pone.0237560.ref024"><label>24</label><mixed-citation publication-type="other">National AIDS Control Program. Report of the pilot study in Karachi &#x00026; Rawalpindi 2004&#x02013;05. Islamabad, Pakistan: 2004&#x02013;2005 NACP-HASP/021.01.2005 Contract No.: NACP-HASP/021.01.2005.</mixed-citation></ref><ref id="pone.0237560.ref025"><label>25</label><mixed-citation publication-type="other">World Health Organization. WHO manual for HIV drug resistance testing using dried blood spot specimens. Geneva, Switzerland: 2012.</mixed-citation></ref><ref id="pone.0237560.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Woods</surname><given-names>CK</given-names></name>, <name><surname>Brumme</surname><given-names>CJ</given-names></name>, <name><surname>Liu</surname><given-names>TF</given-names></name>, <name><surname>Chui</surname><given-names>CK</given-names></name>, <name><surname>Chu</surname><given-names>AL</given-names></name>, <name><surname>Wynhoven</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool</article-title>. <source>J Clin Microbiol</source>. <year>2012</year>;<volume>50</volume>(<issue>6</issue>):<fpage>1936</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.06689-11</pub-id>
<?supplied-pmid 22403431?><pub-id pub-id-type="pmid">22403431</pub-id></mixed-citation></ref><ref id="pone.0237560.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Kumar</surname><given-names>S</given-names></name>, <name><surname>Stecher</surname><given-names>G</given-names></name>, <name><surname>Tamura</surname><given-names>K</given-names></name>. <article-title>MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for bigger datasets</article-title>. <source>Mol Biol Evol</source>. <year>2016</year>;<volume>33</volume>(<issue>7</issue>):<fpage>1870</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msw054</pub-id>
<?supplied-pmid 27004904?><pub-id pub-id-type="pmid">27004904</pub-id></mixed-citation></ref><ref id="pone.0237560.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Altaf</surname><given-names>A</given-names></name>. <article-title>Delays and gaps in HIV programmes in Pakistan</article-title>. <source>The Lancet HIV</source>. <year>2018</year>;<volume>5</volume>(<issue>12</issue>):<fpage>e678</fpage>&#x02013;<lpage>e9</lpage>. <pub-id pub-id-type="doi">10.1016/S2352-3018(18)30252-2</pub-id>
<?supplied-pmid 30527323?><pub-id pub-id-type="pmid">30527323</pub-id></mixed-citation></ref><ref id="pone.0237560.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Pineda-Pena</surname><given-names>AC</given-names></name>, <name><surname>Faria</surname><given-names>NR</given-names></name>, <name><surname>Imbrechts</surname><given-names>S</given-names></name>, <name><surname>Libin</surname><given-names>P</given-names></name>, <name><surname>Abecasis</surname><given-names>AB</given-names></name>, <name><surname>Deforche</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools</article-title>. <source>Infect Genet Evol</source>. <year>2013</year>;<volume>19</volume>:<fpage>337</fpage>&#x02013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.meegid.2013.04.032</pub-id>
<?supplied-pmid 23660484?><pub-id pub-id-type="pmid">23660484</pub-id></mixed-citation></ref><ref id="pone.0237560.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Struck</surname><given-names>D</given-names></name>, <name><surname>Lawyer</surname><given-names>G</given-names></name>, <name><surname>Ternes</surname><given-names>AM</given-names></name>, <name><surname>Schmit</surname><given-names>JC</given-names></name>, <name><surname>Bercoff</surname><given-names>DP</given-names></name>. <article-title>COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification</article-title>. <source>Nucleic Acids Res</source>. <year>2014</year>;<volume>42</volume>(<issue>18</issue>):<fpage>e144</fpage>
<pub-id pub-id-type="doi">10.1093/nar/gku739</pub-id>
<?supplied-pmid 25120265?><pub-id pub-id-type="pmid">25120265</pub-id></mixed-citation></ref><ref id="pone.0237560.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Kosakovsky Pond</surname><given-names>SL</given-names></name>, <name><surname>Posada</surname><given-names>D</given-names></name>, <name><surname>Stawiski</surname><given-names>E</given-names></name>, <name><surname>Chappey</surname><given-names>C</given-names></name>, <name><surname>Poon</surname><given-names>AF</given-names></name>, <name><surname>Hughes</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>An evolutionary model-based algorithm for accurate phylogenetic breakpoint mapping and subtype prediction in HIV-1</article-title>. <source>PLoS Comput Biol</source>. <year>2009</year>;<volume>5</volume>(<issue>11</issue>):<fpage>e1000581</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pcbi.1000581</pub-id>
<?supplied-pmid 19956739?><pub-id pub-id-type="pmid">19956739</pub-id></mixed-citation></ref><ref id="pone.0237560.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Nguyen</surname><given-names>L-T</given-names></name>, <name><surname>Schmidt</surname><given-names>HA</given-names></name>, <name><surname>von Haeseler</surname><given-names>A</given-names></name>, <name><surname>Minh</surname><given-names>BQ</given-names></name>. <article-title>IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies</article-title>. <source>Molecular Biology and Evolution</source>. <year>2015</year>;<volume>32</volume>(<issue>1</issue>):<fpage>268</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msu300</pub-id>
<?supplied-pmid 25371430?><pub-id pub-id-type="pmid">25371430</pub-id></mixed-citation></ref><ref id="pone.0237560.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Minh</surname><given-names>BQ</given-names></name>, <name><surname>Nguyen</surname><given-names>MA</given-names></name>, <name><surname>von Haeseler</surname><given-names>A</given-names></name>. <article-title>Ultrafast approximation for phylogenetic bootstrap</article-title>. <source>Mol Biol Evol</source>. <year>2013</year>;<volume>30</volume>(<issue>5</issue>):<fpage>1188</fpage>&#x02013;<lpage>95</lpage>. Epub 2013/02/19. <pub-id pub-id-type="doi">10.1093/molbev/mst024</pub-id>
<?supplied-pmid 23418397?><pub-id pub-id-type="pmid">23418397</pub-id></mixed-citation></ref><ref id="pone.0237560.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Ragonnet-Cronin</surname><given-names>M</given-names></name>, <name><surname>Hodcroft</surname><given-names>E</given-names></name>, <name><surname>Hue</surname><given-names>S</given-names></name>, <name><surname>Fearnhill</surname><given-names>E</given-names></name>, <name><surname>Delpech</surname><given-names>V</given-names></name>, <name><surname>Brown</surname><given-names>AJL</given-names></name>, <etal>et al</etal>
<article-title>Automated analysis of phylogenetic clusters</article-title>. <source>BMC Bioinformatics</source>. <year>2013</year>;<volume>14</volume>(<issue>317</issue>).</mixed-citation></ref><ref id="pone.0237560.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Poon</surname><given-names>AF</given-names></name>, <name><surname>Joy</surname><given-names>JB</given-names></name>, <name><surname>Woods</surname><given-names>CK</given-names></name>, <name><surname>Shurgold</surname><given-names>S</given-names></name>, <name><surname>Colley</surname><given-names>G</given-names></name>, <name><surname>Brumme</surname><given-names>CJ</given-names></name>, <etal>et al</etal>
<article-title>The impact of clinical, demographic and risk factors on rates of HIV transmission: a population-based phylogenetic analysis in British Columbia, Canada</article-title>. <source>Journal of Infectious Diseases</source>. <year>2015</year>;<volume>211</volume>(<issue>6</issue>):<fpage>926</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiu560</pub-id>
<?supplied-pmid 25312037?><pub-id pub-id-type="pmid">25312037</pub-id></mixed-citation></ref><ref id="pone.0237560.ref036"><label>36</label><mixed-citation publication-type="book"><name><surname>Katoh</surname><given-names>K</given-names></name>, <name><surname>Asimenos</surname><given-names>G</given-names></name>, <name><surname>Toh</surname><given-names>H</given-names></name>. <chapter-title>Multiple Alignment of DNA Sequences with MAFFT</chapter-title> In: <name><surname>Posada</surname><given-names>D</given-names></name>, editor. <source>Bioinformatics for DNA Sequence Analysis</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Humana Press</publisher-name>; <year>2009</year> p. <fpage>39</fpage>&#x02013;<lpage>64</lpage>.</mixed-citation></ref><ref id="pone.0237560.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Larsson</surname><given-names>A</given-names></name>. <article-title>AliView: a fast and lightweight alignment viewer and editor for large datasets</article-title>. <source>Bioinformatics</source>. <year>2014</year>;<volume>30</volume>(<issue>22</issue>):<fpage>3276</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btu531</pub-id>
<?supplied-pmid 25095880?><pub-id pub-id-type="pmid">25095880</pub-id></mixed-citation></ref><ref id="pone.0237560.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Price</surname><given-names>MN</given-names></name>, <name><surname>Dehal</surname><given-names>PS</given-names></name>, <name><surname>Arkin</surname><given-names>AP</given-names></name>. <article-title>FastTree 2&#x02014;Approximately Maximum-Likelihood trees for large alignments</article-title>. <source>PLoS One</source>. <year>2010</year>;<volume>5</volume>(<issue>3</issue>):<fpage>e9490</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0009490</pub-id>
<?supplied-pmid 20224823?><pub-id pub-id-type="pmid">20224823</pub-id></mixed-citation></ref><ref id="pone.0237560.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Suchard</surname><given-names>MA</given-names></name>, <name><surname>Lemey</surname><given-names>P</given-names></name>, <name><surname>Baele</surname><given-names>G</given-names></name>, <name><surname>Ayres</surname><given-names>DL</given-names></name>, <name><surname>Drummond</surname><given-names>AJ</given-names></name>, <name><surname>Rambaut</surname><given-names>A</given-names></name>. <article-title>Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10</article-title>. <source>Virus Evol</source>. <year>2018</year>;<volume>4</volume>(<issue>1</issue>):vey016.</mixed-citation></ref><ref id="pone.0237560.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Jenkins</surname><given-names>GM</given-names></name>, <name><surname>Rambaut</surname><given-names>A</given-names></name>, <name><surname>Pybus</surname><given-names>OG</given-names></name>, <name><surname>Holmes</surname><given-names>EC</given-names></name>. <article-title>Rates of molecular evolution in RNA viruses: A quantitative phylogenetic analysis</article-title>. <source>Journal of Molecular Evolution</source>. <year>2002</year>;<volume>54</volume>(<issue>2</issue>):<fpage>156</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1007/s00239-001-0064-3</pub-id>
<?supplied-pmid 11821909?><pub-id pub-id-type="pmid">11821909</pub-id></mixed-citation></ref><ref id="pone.0237560.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Drummond</surname><given-names>AJ</given-names></name>, <name><surname>Rambaut</surname><given-names>A</given-names></name>, <name><surname>Shapiro</surname><given-names>B</given-names></name>, <name><surname>Pybus</surname><given-names>OG</given-names></name>. <article-title>Bayesian coalescent inference of past population dynamics from molecular sequences</article-title>. <source>Mol Biol Evol</source>. <year>2005</year>;<volume>22</volume>(<issue>5</issue>):<fpage>1185</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msi103</pub-id>
<?supplied-pmid 15703244?><pub-id pub-id-type="pmid">15703244</pub-id></mixed-citation></ref><ref id="pone.0237560.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Baele</surname><given-names>G</given-names></name>, <name><surname>Lemey</surname><given-names>P</given-names></name>, <name><surname>Suchard</surname><given-names>MA</given-names></name>. <article-title>Genealogical working distributions for Bayesian model testing with phylogenetic uncertainty</article-title>. <source>Syst Biol</source>. <year>2016</year>;<volume>65</volume>(<issue>2</issue>):<fpage>250</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1093/sysbio/syv083</pub-id>
<?supplied-pmid 26526428?><pub-id pub-id-type="pmid">26526428</pub-id></mixed-citation></ref><ref id="pone.0237560.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Rambaut</surname><given-names>A</given-names></name>, <name><surname>Drummond</surname><given-names>AJ</given-names></name>, <name><surname>Xie</surname><given-names>D</given-names></name>, <name><surname>Baele</surname><given-names>G</given-names></name>, <name><surname>Suchard</surname><given-names>MA</given-names></name>. <article-title>Posterior summarization in Bayesian phylogenetics using Tracer 1.7</article-title>. <source>Syst Biol</source>. <year>2018</year>;<volume>67</volume>(<issue>5</issue>):<fpage>901</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1093/sysbio/syy032</pub-id>
<?supplied-pmid 29718447?><pub-id pub-id-type="pmid">29718447</pub-id></mixed-citation></ref><ref id="pone.0237560.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Martin</surname><given-names>DP</given-names></name>, <name><surname>Murrell</surname><given-names>B</given-names></name>, <name><surname>Golden</surname><given-names>M</given-names></name>, <name><surname>Khoosal</surname><given-names>A</given-names></name>, <name><surname>Muhire</surname><given-names>B</given-names></name>. <article-title>RDP4: Detection and analysis of recombination patterns in virus genomes</article-title>. <source>Virus Evol</source>. <year>2015</year>;<volume>1</volume>(<issue>1</issue>):vev003.</mixed-citation></ref><ref id="pone.0237560.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Vaughan</surname><given-names>TG</given-names></name>, <name><surname>Kuhnert</surname><given-names>D</given-names></name>, <name><surname>Popinga</surname><given-names>A</given-names></name>, <name><surname>Welch</surname><given-names>D</given-names></name>, <name><surname>Drummond</surname><given-names>AJ</given-names></name>. <article-title>Efficient Bayesian inference under the structured coalescent</article-title>. <source>Bioinformatics</source>. <year>2014</year>;<volume>30</volume>(<issue>16</issue>):<fpage>2272</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btu201</pub-id>
<?supplied-pmid 24753484?><pub-id pub-id-type="pmid">24753484</pub-id></mixed-citation></ref><ref id="pone.0237560.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Bouckaert</surname><given-names>R</given-names></name>, <name><surname>Heled</surname><given-names>J</given-names></name>, <name><surname>Kuhnert</surname><given-names>D</given-names></name>, <name><surname>Vaughan</surname><given-names>T</given-names></name>, <name><surname>Wu</surname><given-names>CH</given-names></name>, <name><surname>Xie</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>BEAST 2: a software platform for Bayesian evolutionary analysis</article-title>. <source>PLoS Comput Biol</source>. <year>2014</year>;<volume>10</volume>(<issue>4</issue>):<fpage>e1003537</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pcbi.1003537</pub-id>
<?supplied-pmid 24722319?><pub-id pub-id-type="pmid">24722319</pub-id></mixed-citation></ref></ref-list></back></article>